Early detection of transformation to BPDCN in a patient with MDS.
Kamal ChamounSanam LoghaviNaveen PemmarajuMarina KonoplevaMichael KrollMadeleine Nguyen-CaoMarisa HornbakerCourtney D DiNardoTapan KadiaJeffrey JorgensenMichael AndreeffShimin HuChristopher B BentonPublished in: Experimental hematology & oncology (2018)
The case demonstrates that minimal transformative disease of BPDCN may be detectable in patients with MDS well before fulminant progression. Early detection of emerging leukemic clones may allow for alternative monitoring and treatment considerations.
Keyphrases